Sign In
Buy ZTS
$74.17
-1.16 (-1.54%)
At Close: Jul 22, 2026
Why Zoetis (ZTS) Could Beat Earnings Estimates Again
01:11pm, Friday, 18'th Jul 2025
Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zoetis: Poised For Growth Yet Priced For Decline (Rating Upgrade To Strong Buy)
09:30am, Friday, 18'th Jul 2025
Zoetis Inc. is the dominant animal health company, growing market share, revenue, and margins, now trading at a multi-year low valuation. Fundamentals remain strong: rising EPS, aggressive buybacks, a
Here's Why Zoetis (ZTS) is a Strong Growth Stock
10:46am, Thursday, 17'th Jul 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Phibro's Feed Play Pays Off: JPMorgan Upgrades On Zoetis Deal Boost
02:30pm, Monday, 07'th Jul 2025
JPMorgan upgraded Phibro Animal Health Corporation PAHC, citing strong execution following its $350 million acquisition of Zoetis' medicated feed additive and water-soluble product portfolio.
SGIOY or ZTS: Which Is the Better Value Stock Right Now?
12:41pm, Monday, 07'th Jul 2025
Investors looking for stocks in the Medical - Drugs sector might want to consider either Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) or Zoetis (ZTS).
3 Magnificent S&P 500 Dividend Stocks Down 19% to 26%: Is It Time to Buy the Dip?
05:54am, Monday, 07'th Jul 2025
I am an adherent to the Gardner-Kretzmann Continuum's strategy of owning at least one stock for each year of your age. Because of this notion, I have 37 "core" holdings that I try to add to consistent
2 Dividend Growth Stocks to Buy and Hold Forever
07:05am, Sunday, 06'th Jul 2025
For investors focused on the long game, there is little reason to sell -- at least, so long as a company generates solid returns through consistently improving financial results, regularly increases i
Zoetis: Growth To Continue Thanks To Companion Animals
01:11am, Thursday, 03'rd Jul 2025
Zoetis remains a compelling long-term investment, driven by strong growth in companion animal products and a resilient pet care market. Despite recent underperformance and valuation concerns, Zoetis's
Here's Why Zoetis (ZTS) is a Strong Growth Stock
10:45am, Tuesday, 01'st Jul 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zoetis to Host Webcast and Conference Call on Second Quarter 2025 Financial Results
08:30am, Tuesday, 01'st Jul 2025
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, August 5, 2025. Chief Executive Officer Kristin P
Should You Invest in Zoetis (ZTS) Based on Bullish Wall Street Views?
10:31am, Friday, 27'th Jun 2025
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
Phibro Animal Health: The Animal Is Unleashed
04:19am, Wednesday, 25'th Jun 2025
Phibro Animal Health's acquisition of Zoetis' medicated feed additive business has driven significant momentum and improved financial performance. Organic growth and margin expansion is seen across al
SGIOY or ZTS: Which Is the Better Value Stock Right Now?
12:41pm, Friday, 20'th Jun 2025
Investors interested in stocks from the Medical - Drugs sector have probably already heard of Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) and Zoetis (ZTS).
Zoetis (ZTS) Suffers a Larger Drop Than the General Market: Key Insights
07:16pm, Wednesday, 18'th Jun 2025
Zoetis (ZTS) closed at $155.06 in the latest trading session, marking a -4.09% move from the prior day.
Zoetis Stock Is Falling. Why the Animal-Health Company Was Downgraded.
12:46pm, Wednesday, 18'th Jun 2025
The Merck rival faces intense competition that could limit multiple expansion, Stifel analysts say.
